Other OTC Pharmaceuticals - Panama

  • Panama
  • In Panama, the revenue generated in the Other OTC Pharmaceuticals market in 2024 amounts to US$23.15m.
  • It is projected that this market will experience an annual growth rate of 1.99% (CAGR 2024-2029).
  • When compared globally, the in the United States generates the highest revenue in this market, with a total of US$7,171.00m in 2024.
  • In terms of per person revenues, in 2024, each individual in Panama contributes US$5.11 to the overall revenue of the Other OTC Pharmaceuticals market.
  • Panama's Other OTC Pharmaceuticals market is witnessing a surge in demand for natural remedies and herbal supplements.

Key regions: Europe, Germany, United States, Brazil, Australia

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The Other OTC Pharmaceuticals market in Panama has been steadily growing in recent years, driven by various factors such as changing customer preferences, market trends, local special circumstances, and underlying macroeconomic factors.

Customer preferences:
In Panama, customers have shown a growing preference for over-the-counter (OTC) pharmaceuticals due to their convenience and accessibility. OTC medications do not require a prescription and can be easily purchased at pharmacies and supermarkets. This convenience factor has led to an increase in demand for OTC pharmaceuticals among consumers who prefer self-medication for minor ailments and common health issues.

Trends in the market:
One of the key trends in the Other OTC Pharmaceuticals market in Panama is the increasing demand for natural and herbal remedies. Consumers are becoming more health-conscious and are seeking alternative treatments that are perceived as safer and more natural. This trend is driving the growth of herbal and natural OTC pharmaceutical products in the market.Another trend in the market is the rise of e-commerce platforms for the sale of OTC pharmaceuticals. Online shopping has gained popularity in Panama, and consumers are increasingly turning to online platforms to purchase OTC medications. The convenience of online shopping, coupled with competitive pricing and a wide range of product options, has contributed to the growth of e-commerce in the OTC pharmaceutical market.

Local special circumstances:
Panama's growing aging population is a significant local special circumstance that is impacting the Other OTC Pharmaceuticals market. As the population ages, there is an increased demand for OTC medications that cater to age-related health issues such as joint pain, digestive problems, and cardiovascular health. Manufacturers and retailers are responding to this demand by offering specialized OTC pharmaceutical products targeted towards the elderly population.

Underlying macroeconomic factors:
The overall economic growth and stability in Panama have contributed to the development of the Other OTC Pharmaceuticals market. As the economy continues to grow, disposable incomes are increasing, allowing consumers to spend more on healthcare products, including OTC pharmaceuticals. Additionally, the government's focus on improving healthcare infrastructure and increasing access to healthcare services has also positively influenced the market.In conclusion, the Other OTC Pharmaceuticals market in Panama is experiencing growth due to changing customer preferences, market trends, local special circumstances, and underlying macroeconomic factors. The convenience and accessibility of OTC medications, coupled with the rising demand for natural and herbal remedies, are driving the market forward. Furthermore, the increasing popularity of e-commerce platforms and the growing aging population in Panama are additional factors contributing to the market's development. The overall economic growth and government initiatives in the healthcare sector are also playing a significant role in the market's expansion.

Methodology

Data coverage:

Data encompasses B2C spend. Figures are based on the OTC Pharmaceuticals market values, representing revenues generated by both product sales which take place exclusively in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use data from national statistical offices, international institutions, trade associations, and self-medication associations. Next, we use relevant key market indicators and data from country-specific associations, such as consumer healthcare spending, out-of-pocket healthcare expenditure, health system accessibilities, and GDP. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. Whereas this market covers only OTC drugs, the Statista Pharmaceuticals market covers both OTC and prescription drugs.

Overview

  • Revenue
  • Analyst Opinion
  • Global Comparison
  • Methodology
  • Key Market Indicators
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Kisara Mizuno
Kisara Mizuno
Senior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)